| Akcje zaległe | 278,291,590 shares |
| Akcje insidera | 93 665 391 shares |
| Własność insidera | 33,66 % |
| Insiderzy ogółem | 23 |
Wynik sentymentu insiderów
Ocena sentymentu insiderów pokazuje firmy, które są kupowane przez insiderów korporacyjnych.
Jest to wynik zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje spółki o najwyższym poziomie akumulacji informacji poufnych. Model rankingowy wykorzystuje kombinację liczby netto insiderów kupujących w ciągu ostatnich 90 dni, całkowitej liczby akcji kupionych jako procent akcji w obrocie oraz całkowitej liczby akcji posiadanych przez insiderów. Liczba ta waha się od 0 do 100, przy czym wyższe liczby wskazują na wyższy poziom akumulacji w porównaniu z innymi spółkami, a 50 to średnia.
Częstotliwość aktualizacji: codziennie
Ocena sentymentu kadry kierowniczej
Ocena sentymentu kadry kierowniczej pokazuje, że firmy są kupowane przez urzędników korporacyjnych.
Z definicji dyrektorzy korporacyjni to insiderzy korporacyjni, ale w przeciwieństwie do niektórych innych insiderów (10% akcjonariuszy i członków zarządu), dyrektorzy pracują dla firmy na co dzień i podczas handlu korzystają z własnych pieniędzy. (10% Akcjonariusze i członkowie zarządu często zarządzają funduszami zarządzających pieniędzmi innych osób). W związku z tym transakcje wykorzystujące informacje poufne dokonywane przez osoby z kadry kierowniczej mają znacznie większe znaczenie i powinny być odpowiednio traktowane.
Podobnie jak ocena sentymentu insiderów, ocena sentymentu kadry kierowniczej jest wynikiem zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje firmy o najwyższym poziomie akumulacji urzędników.
Częstotliwość aktualizacji: codziennie
Kluczowe wskaźniki insider
Ta karta pokazuje pozycję firmy według różnych wskaźników insider. Ranking według miary percentyla pokazuje, jak ta firma wypada na tle innych firm na rynkach amerykańskich. Wyższe rankingi wskazują na lepszą sytuację.
Na przykład ogólnie przyjmuje się, że kupowanie przez insiderów jest pozytywnym wskaźnikiem, zatem spółki z większą liczbą takich transakcji plasowałyby się wyżej niż spółki z mniejszą liczbą takich transakcji (lub nawet sprzedaży przez insiderów.
Liczba netto zakupów dokonanych przez insiderów (ranking)
5432 out of 10948
Liczba netto zakupów dokonanych przez insiderów to łączna liczba insiderów kupujących pomniejszona o całkowitą liczbę insiderów sprzedających w ciągu ostatnich 90 dni. Tutaj pokazana jest miara percentyla (zakres od 0 do 100%).
Procent akcji kupowanych przez insiderów (ranking)
5373 out of 10786
Procent akcji zakupionych przez insiderów to całkowita liczba akcji zakupionych przez insiderów pomniejszona o całkowitą liczbę akcji sprzedanych przez insiderów w ciągu ostatnich 90 dni, podzielona przez całkowitą liczbę akcji zakupionych przez insiderów i pomnożona przez 100.
Wykres handlu insider
Poniższy wykres przedstawia Sana Biotechnology, Inc. transakcji zrealizowanych przez insiderów. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Ogólnie rzecz biorąc, dokonywanie transakcji w ich firmach przez osoby posiadające dostęp do informacji poufnych w oparciu o istotne, niepubliczne informacje jest generalnie nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4.
Lista insiderów i wskaźniki rentowności
Ta tabela przedstawia listę znanych insiderów i jest generowana automatycznie na podstawie zgłoszeń ujawnianych SEC. Oprócz nazwisk, najnowszego tytułu oraz oznaczenia dyrektora, członka kierownictwa lub 10% właściciela, podajemy najnowsze ujawnione pakiety akcji. Dodatkowo, jeśli to możliwe, udostępniamy historyczne wyniki handlowe danego insidera. Historyczne wyniki handlowe to średnia ważona wyników rzeczywistych transakcji zakupu na otwartym rynku dokonanych przez insiderów. Więcej informacji na temat sposobu obliczania tej wartości obejrzyj webinar na YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|---|---|---|
|
Noubar Afeyan
10% Owner -
|
11 585 199 | 0 | |
| Sunil Agarwal EVP, Head of Development & CMO - [O] | 1 550 000 | 1 550 000 | |
|
ARCH Venture Fund X, L.P.
10% Owner -
|
22 747 272 | 22 747 272 | |
|
ARCH Venture Partners X, LLC
10% Owner -
|
11 718 750 | 22 747 272 | |
| Bilenker Joshua H. Director - [D] | 20 000 | 20 000 | |
| Hans Edgar Bishop Director - [D] | 5 848 503 | 5 848 503 | |
|
Keith Crandell
10% Owner -
|
22 747 272 | 22 747 272 |
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|---|---|---|
| Bernard J Cassidy EVP & General Counsel - [O] | 112 990 | 112 990 | |
|
FMR LLC / Fidelity Management & Research
10% Owner -
|
4 541 572 | 4 541 572 | |
|
Flagship Ventures Fund V General Partner LLC
10% Owner -
|
22 546 725 | 0 | |
|
Flagship Ventures Management, Inc.
10% Owner -
|
0 | 0 | |
|
Steven Gillis
10% Owner -
|
11 718 750 | 22 747 272 | |
| Nathan Hardy SVP, Chief Financial Officer - [O] | 511 250 | 511 250 | |
| Steve Harr President & CEO, Director - [D] [O] | 7 944 251 | 7 944 251 | |
| Christian Hordo EVP, Chief Business Officer - [O] | 867 455 | 867 455 |
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|---|---|---|
| MacDonald James J. EVP & General Counsel - [O] | 497 396 | 497 396 | |
| Richard Mulligan Director - [D] | 2 698 121 | 2 698 121 | |
|
Robert Nelsen
Director, 10% Owner -
[D]
|
22 761 125 | 22 761 125 | |
| Dhavalkumar Dhirajlal Patel EVP, Chief Scientific Officer - [O] | 99 510 | 99 510 | |
| Mary Agnes Wilderotter Director - [D] | 7 106 | 7 106 | |
| Wyrick Susan D. See Remarks - [O] | 196 196 | 196 196 | |
| Patrick Y Yang Director - [D] | 149 250 | 149 250 | |
| Maltzahn Geoffrey von Director - [D] | 366 122 | 366 122 |
Report errors via our new Insider Auditing Tool
Śledź historię zakupów insiderów — analiza zysków krótkoterminowych
W tej sekcji analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w SANA / Sana Biotechnology, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Śledź historię sprzedaży insider — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży insidera na otwartym rynku dokonanej w SANA / Sana Biotechnology, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia transakcji
Kliknij ikonę linku, aby zobaczyć pełną historię transakcji. Transakcje zgłoszone w ramach automatycznego planu handlowego 10b5-1 będą oznaczone znakiem X w kolumnie oznaczonej 10b-5.
| Plik Data |
Data transakcji |
Formularz | Wtajemniczony | Serce | Nazwa papieru wartościowego | Kod | Bezpośredni | Cena wykonania |
Cena jednostki |
Zmieniono jednostki |
Zmieniona wartość (1 tys.) |
Pozostałe opcje |
Pozostałe akcje |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-08 | 2026-04-06 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 7 763 | 5 848 503 | ||||||
| 2026-03-27 | 3 | PATEL DHAVALKUMAR DHIRAJLAL | SANA | Common Stock | D | 99 510 | ||||||||
| 2026-03-10 | 2026-03-09 | 4 | Harr Steve | SANA | Common Stock | D | 3,1000 | -12 819 | -40 | 7 944 251 | ||||
| 2026-03-10 | 2026-03-09 | 4 | Harr Steve | SANA | Common Stock | D | 3,1300 | -11 526 | -36 | 7 957 070 | ||||
| 2026-03-10 | 2026-03-07 | 4 | Harr Steve | SANA | Common Stock | D | 50 000 | 7 968 596 | ||||||
| 2026-03-10 | 2026-03-06 | 4 | Harr Steve | SANA | Common Stock | D | 41 666 | 7 918 596 | ||||||
| 2026-03-10 | 2026-03-09 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3,1000 | -1 045 | -3 | 196 196 | ||||
| 2026-03-10 | 2026-03-09 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3,1300 | -3 342 | -10 | 197 241 | ||||
| 2026-03-10 | 2026-03-07 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3 250 | 200 583 | ||||||
| 2026-03-10 | 2026-03-06 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 10 416 | 197 333 | ||||||
| 2026-03-04 | 2026-03-03 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3,9100 | -491 | -2 | 186 917 | ||||
| 2026-03-04 | 2026-03-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 1 525 | 187 408 | ||||||
| 2026-01-06 | 2026-01-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 6 157 | 5 840 740 | ||||||
| 2026-01-06 | 2026-01-05 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 4,2700 | -2 407 | -10 | 185 883 | ||||
| 2026-01-06 | 2026-01-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 7 500 | 188 290 | ||||||
| 2025-12-16 | 2025-12-15 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 5,2200 | -873 | -5 | 180 790 | ||||
| 2025-12-16 | 2025-12-13 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3 400 | 181 663 | ||||||
| 2025-12-05 | 2025-12-04 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 4,4400 | -2 565 | -11 | 178 263 | ||||
| 2025-12-05 | 2025-12-03 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 10 000 | 180 828 | ||||||
| 2025-12-05 | 2025-06-04 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 2,3200 | -2 567 | -6 | 167 828 | ||||
| 2025-12-05 | 2025-06-03 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 10 000 | 170 395 | ||||||
| 2025-10-07 | 2025-10-06 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 5 628 | 5 834 583 | ||||||
| 2025-07-08 | 2025-07-07 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 7 842 | 5 828 955 | ||||||
| 2025-04-08 | 2025-04-07 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 16 339 | 5 821 113 | ||||||
| 2025-03-10 | 2025-03-10 | 4 | Harr Steve | SANA | Common Stock | D | 2,5600 | -12 820 | -33 | 7 876 930 | ||||
| 2025-03-10 | 2025-03-07 | 4 | Harr Steve | SANA | Common Stock | D | 50 000 | 7 889 750 | ||||||
| 2025-03-10 | 2025-03-10 | 4 | Cassidy Bernard J | SANA | Common Stock | D | 2,5600 | -2 833 | -7 | 112 990 | ||||
| 2025-03-10 | 2025-03-07 | 4 | Cassidy Bernard J | SANA | Common Stock | D | 11 041 | 115 823 | ||||||
| 2025-03-10 | 2025-03-10 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 2,5600 | -836 | -2 | 157 395 | ||||
| 2025-03-10 | 2025-03-07 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3 250 | 158 231 | ||||||
| 2025-03-03 | 2025-03-03 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 2,5600 | -490 | -1 | 154 981 | ||||
| 2025-03-03 | 2025-03-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 1 525 | 155 471 | ||||||
| 2025-01-10 | 2025-01-08 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 7,2600 | -1 000 | -7 | 4 541 511 | ||||
| 2025-01-10 | 2025-01-08 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 6,7100 | -164 912 | -1 107 | 4 542 511 | ||||
| 2025-01-10 | 2025-01-08 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 6,5000 | -25 000 | -162 | 4 707 423 | ||||
| 2025-01-10 | 2025-01-08 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 6,1100 | -100 000 | -611 | 4 732 423 | ||||
| 2025-01-07 | 2025-01-06 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 14 285 | 5 804 774 | ||||||
| 2025-01-03 | 2025-01-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 1,6500 | -1 566 | -3 | 153 946 | ||||
| 2025-01-03 | 2025-01-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 5 000 | 155 512 | ||||||
| 2024-11-21 | 3/A | FMR LLC / Fidelity Management & Research FMR Capital, Inc. | SANA | Common Stock | I | 61 | ||||||||
| 2024-10-15 | 3 | Wyrick Susan D. | SANA | Common Stock | D | 147 512 | ||||||||
| 2024-10-09 | 2024-10-07 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 5 938 | 5 790 489 | ||||||
| 2024-09-26 | 2024-09-25 | 4 | Mulligan Richard | SANA | Common Stock | D | 3,8878 | -150 000 | -583 | 2 698 121 | ||||
| 2024-09-26 | 2024-09-24 | 4 | Mulligan Richard | SANA | Common Stock | D | 4,0838 | -150 000 | -613 | 2 848 121 | ||||
| 2024-07-08 | 2024-07-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 4 911 | 5 784 551 | ||||||
| 2024-04-08 | 2024-04-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 2 774 | 5 779 640 | ||||||
| 2024-04-08 | 3 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 4 832 423 | ||||||||
| 2024-03-11 | 2024-03-08 | 4 | Yang Patrick Y | SANA | Common Stock | D | 9,4520 | -25 000 | -236 | 149 250 | ||||
| 2024-02-12 | 2024-02-08 | 4 | NELSEN ROBERT | SANA | Common Stock | I | 5,5000 | 727 272 | 4 000 | 12 446 022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | NELSEN ROBERT | SANA | Common Stock | I | 5,5000 | 727 272 | 4 000 | 12 446 022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | NELSEN ROBERT | SANA | Common Stock | I | 5,5000 | 363 637 | 2 000 | 10 667 387 | ||||
| 2024-02-12 | 2024-02-08 | 4 | CRANDELL KEITH | SANA | Common Stock | I | 5,5000 | 727 272 | 4 000 | 12 446 022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | CRANDELL KEITH | SANA | Common Stock | I | 5,5000 | 727 272 | 4 000 | 12 446 022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | CRANDELL KEITH | SANA | Common Stock | I | 5,5000 | 363 637 | 2 000 | 10 667 387 | ||||
| 2024-02-12 | 2024-02-08 | 4 | ARCH Venture Fund X, L.P. | SANA | Common Stock | I | 5,5000 | 727 272 | 4 000 | 12 446 022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | ARCH Venture Fund X, L.P. | SANA | Common Stock | I | 5,5000 | 727 272 | 4 000 | 12 446 022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | ARCH Venture Fund X, L.P. | SANA | Common Stock | I | 5,5000 | 363 637 | 2 000 | 10 667 387 | ||||
| 2024-01-08 | 2024-01-05 | 4 | Wilderotter Mary Agnes | SANA | Common Stock | D | 1 470 | 7 106 | ||||||
| 2024-01-08 | 2024-01-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 4 901 | 5 776 866 | ||||||
| 2023-12-18 | 2023-12-15 | 4 | Hordo Christian | SANA | Common Stock | D | 4,0013 | -75 000 | -300 | 867 455 | ||||
| 2023-10-06 | 2023-10-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 6 925 | 5 771 965 | ||||||
| 2023-10-06 | 2023-10-05 | 4 | Wilderotter Mary Agnes | SANA | Common Stock | D | 2 077 | 5 636 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship Pioneering Fund VI General Partner LLC | SANA | Common Stock | I | -70 813 | 0 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship Pioneering Fund VI, L.P. | SANA | Common Stock | I | -2 431 281 | 7 293 841 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship Ventures Fund V General Partner LLC | SANA | Common Stock | I | -1 181 745 | 0 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | -345 069 | 1 035 208 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | -4 926 378 | 8 057 470 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship VentureLabs V, LLC | SANA | Common Stock | I | -2 825 989 | 8 615 337 | ||||||
| 2023-07-06 | 2023-07-05 | 4 | Wilderotter Mary Agnes | SANA | Common Stock | D | 1 245 | 3 559 | ||||||
| 2023-07-06 | 2023-07-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 4 152 | 5 765 040 | ||||||
| 2023-06-08 | 2023-06-07 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6,2397 | -22 760 | -142 | 1 380 277 | ||||
| 2023-06-08 | 2023-06-07 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6,2397 | -177 240 | -1 106 | 10 743 293 | ||||
| 2023-06-08 | 2023-06-06 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6,3061 | -22 297 | -141 | 1 403 037 | ||||
| 2023-06-08 | 2023-06-06 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6,3061 | -181 461 | -1 144 | 10 920 533 | ||||
| 2023-05-26 | 2023-05-26 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6,2265 | -9 330 | -58 | 1 425 334 | ||||
| 2023-05-26 | 2023-05-26 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6,2265 | -72 670 | -452 | 11 101 994 | ||||
| 2023-05-26 | 2023-05-25 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6,3522 | -13 127 | -83 | 1 434 664 | ||||
| 2023-05-26 | 2023-05-25 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6,3522 | -102 245 | -649 | 11 174 664 | ||||
| 2023-05-26 | 2023-05-24 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6,5652 | -39 580 | -260 | 1 447 791 | ||||
| 2023-05-26 | 2023-05-24 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6,5652 | -308 290 | -2 024 | 11 276 909 | ||||
| 2023-04-06 | 2023-04-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 7 716 | 5 760 888 | ||||||
| 2023-04-06 | 2023-04-05 | 4 | Wilderotter Mary Agnes | SANA | Common Stock | D | 2 314 | 2 314 | ||||||
| 2023-02-17 | 2021-02-03 | 4 | Bilenker Joshua H. | SANA | Common Stock | D | 25,0000 | 20 000 | 500 | 20 000 | ||||
| 2023-01-06 | 2023-01-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 6 702 | 5 753 172 | ||||||
| 2023-01-06 | 2023-01-05 | 4 | NELSEN ROBERT | SANA | Common Stock | D | 536 | 1 353 | ||||||
| 2022-10-06 | 2022-10-05 | 4 | NELSEN ROBERT | SANA | Common Stock | D | 321 | 817 | ||||||
| 2022-10-06 | 2022-10-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 4 012 | 5 746 470 | ||||||
| 2022-09-20 | 3/A | Cassidy Bernard J | SANA | Common Stock | D | 92 781 | ||||||||
| 2022-09-16 | 3 | Cassidy Bernard J | SANA | Common Stock | D | 82 031 | ||||||||
| 2022-07-07 | 2022-07-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 3 328 | 5 742 458 | ||||||
| 2022-07-07 | 2022-07-05 | 4 | NELSEN ROBERT | SANA | Common Stock | D | 266 | 496 | ||||||
| 2022-06-15 | 2022-06-13 | 4 | MacDonald James J. | SANA | Common Stock | D | 1,4800 | 66 796 | 99 | 497 396 | ||||
| 2022-06-15 | 2022-05-13 | 4 | MacDonald James J. | SANA | Common Stock | D | 4,2840 | 1 183 | 5 | 430 600 | ||||
| 2022-04-15 | 2021-04-14 | 4 | Harr Steve | SANA | Common Stock | D | -167 000 | 7 839 750 | ||||||
| 2022-04-15 | 2021-04-14 | 4 | Harr Steve | SANA | Common Stock | D | -167 000 | 7 839 750 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 2 880 | 5 739 130 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | NELSEN ROBERT | SANA | Common Stock | D | 230 | 230 | ||||||
| 2022-03-22 | 2022-03-21 | 4 | Yang Patrick Y | SANA | Common Stock | D | 7,3000 | 28 000 | 204 | 174 250 | ||||
| 2022-03-08 | 2022-03-03 | 4 | Harr Steve | SANA | Stock Options (Right to Buy) | D | 5,70 | 760 000 | 760 000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | AGARWAL SUNIL | SANA | Stock Options (Right to Buy) | D | 5,70 | 250 000 | 250 000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | Mulligan Richard | SANA | Stock Options (Right to Buy) | D | 5,70 | 250 000 | 250 000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | Hordo Christian | SANA | Stock Options (Right to Buy) | D | 5,70 | 225 000 | 225 000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | MacDonald James J. | SANA | Stock Options (Right to Buy) | D | 5,70 | 225 000 | 225 000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | Hardy Nathan | SANA | Stock Options (Right to Buy) | D | 5,70 | 225 000 | 225 000 | |||||
| 2022-02-23 | 2022-02-18 | 4 | MacDonald James J. | SANA | Common Stock | D | 6,2800 | -333 | -2 | 429 417 | ||||
| 2022-02-23 | 2021-11-15 | 4 | MacDonald James J. | SANA | Common Stock | D | 18,2325 | 1 000 | 18 | 429 750 | ||||
| 2021-09-17 | 2021-09-16 | 4 | AGARWAL SUNIL | SANA | Common Stock | D | 26,0000 | -1 627 | -42 | 1 550 000 | ||||
| 2021-09-17 | 2021-09-15 | 4 | AGARWAL SUNIL | SANA | Common Stock | D | 26,0695 | -58 373 | -1 522 | 1 551 627 | ||||
| 2021-09-14 | 2021-09-10 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0000 | -1 477 | -37 | 942 455 | ||||
| 2021-09-10 | 2021-09-09 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1,48 | -39 205 | 88 803 | |||||
| 2021-09-10 | 2021-09-09 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0081 | -25 466 | -637 | 943 932 | ||||
| 2021-09-10 | 2021-09-09 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0130 | -39 205 | -981 | 969 398 | ||||
| 2021-09-10 | 2021-09-09 | 4 | Hordo Christian | SANA | Common Stock | D | 1,4800 | 39 205 | 58 | 1 008 603 | ||||
| 2021-09-07 | 2021-09-03 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1,48 | -700 | 128 008 | |||||
| 2021-09-07 | 2021-09-03 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0000 | -700 | -18 | 969 398 | ||||
| 2021-09-07 | 2021-09-03 | 4 | Hordo Christian | SANA | Common Stock | D | 1,4800 | 700 | 1 | 970 098 | ||||
| 2021-09-07 | 2021-09-02 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1,48 | -6 558 | 128 708 | |||||
| 2021-09-07 | 2021-09-02 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0039 | -1 400 | -35 | 969 398 | ||||
| 2021-09-07 | 2021-09-02 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0019 | -6 558 | -164 | 970 798 | ||||
| 2021-09-07 | 2021-09-02 | 4 | Hordo Christian | SANA | Common Stock | D | 1,4800 | 6 558 | 10 | 977 356 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1,48 | -1 134 | 135 266 | |||||
| 2021-09-03 | 2021-09-01 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0057 | -3 002 | -75 | 970 798 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0036 | -1 134 | -28 | 973 800 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Hordo Christian | SANA | Common Stock | D | 1,4800 | 1 134 | 2 | 974 934 | ||||
| 2021-09-01 | 2021-08-30 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1,48 | -1 100 | 136 400 | |||||
| 2021-09-01 | 2021-08-30 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0183 | -1 200 | -30 | 973 800 | ||||
| 2021-09-01 | 2021-08-30 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0100 | -1 100 | -28 | 975 000 | ||||
| 2021-09-01 | 2021-08-30 | 4 | Hordo Christian | SANA | Common Stock | D | 1,4800 | 1 100 | 2 | 976 100 | ||||
| 2021-04-27 | 2021-04-21 | 4 | NELSEN ROBERT | SANA | Common Stock | I | 12 500 | 12 500 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -2 343 750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -2 343 750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -781 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -781 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -5 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -5 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -9 375 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -9 375 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | -3 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | -3 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 11 718 750 | 11 718 750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 11 718 750 | 11 718 750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 10 156 250 | 10 301 250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 10 156 250 | 10 301 250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -2 343 750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -2 343 750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -781 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | -781 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -5 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -5 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -9 375 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -9 375 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | -3 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | -3 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 11 718 750 | 11 718 750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 11 718 750 | 11 718 750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 10 156 250 | 10 301 250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 10 156 250 | 10 301 250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -11 585 199 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -11 441 326 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -9 725 122 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -1 487 371 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Common Stock | I | 11 585 199 | 11 585 199 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Common Stock | I | 11 441 326 | 11 441 326 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Common Stock | I | 9 725 122 | 9 725 122 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Common Stock | I | 1 487 371 | 1 487 371 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Bishop Hans Edgar | SANA | Series B Convertible Preferred Stock | D | -156 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Bishop Hans Edgar | SANA | Series A-2 Convertible Preferred Stock | D | -800 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Bishop Hans Edgar | SANA | Series A-1 Convertible Preferred Stock | D | -1 075 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 2 031 250 | 5 736 250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series B Convertible Preferred Stock | I | -2 343 750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series B Convertible Preferred Stock | I | -2 343 750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series B Convertible Preferred Stock | I | -781 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series B Convertible Preferred Stock | I | -781 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -5 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -5 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -9 375 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | -9 375 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | -3 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | -3 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 11 718 750 | 11 718 750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 11 718 750 | 11 718 750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 10 156 250 | 10 301 250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 10 156 250 | 10 301 250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | von Maltzahn Geoffrey Held by the Geoffrey A. von Malzahn 2020 GRAT | SANA | Series A-2 Convertible Preferred Stock | I | -366 122 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | von Maltzahn Geoffrey | SANA | Series A-2 Convertible Preferred Stock | D | -1 464 488 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | von Maltzahn Geoffrey Held by the Geoffrey A. von Malzahn 2020 GRAT | SANA | Common Stock | I | 366 122 | 366 122 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | von Maltzahn Geoffrey | SANA | Common Stock | D | 1 464 488 | 1 464 488 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Harr Steve | SANA | Series B Convertible Preferred Stock | D | -156 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Harr Steve | SANA | Series A-2 Convertible Preferred Stock | D | -800 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Harr Steve | SANA | Series A-1 Convertible Preferred Stock | D | -1 075 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Harr Steve | SANA | Common Stock | D | 2 031 250 | 8 173 750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | MacDonald James J. Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10 | SANA | Series B Convertible Preferred Stock | I | -7 812 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | MacDonald James J. | SANA | Series A-1 Convertible Preferred Stock | D | -93 750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | MacDonald James J. Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10 | SANA | Common Stock | I | 7 812 | 7 812 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | MacDonald James J. | SANA | Common Stock | D | 93 750 | 428 750 | ||||||
| 2021-02-05 | 2021-02-03 | 4 | NELSEN ROBERT | SANA | Stock Option (Right to Buy) | D | 25,00 | 14 000 | 14 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | von Maltzahn Geoffrey | SANA | Stock Option (Right to Buy) | D | 25,00 | 14 000 | 14 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Bishop Hans Edgar | SANA | Stock Option (Right to Buy) | D | 25,00 | 14 000 | 14 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | AGARWAL SUNIL | SANA | Stock Option (Right to Buy) | D | 25,00 | 48 000 | 48 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Bilenker Joshua H. | SANA | Stock Option (Right to Buy) | D | 25,00 | 7 000 | 7 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Cole Douglas G. | SANA | Stock Option (Right to Buy) | D | 25,00 | 14 000 | 14 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Wilderotter Mary Agnes | SANA | Stock Option (Right to Buy) | D | 25,00 | 14 000 | 14 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Seitz Michelle | SANA | Stock Option (Right to Buy) | D | 25,00 | 7 000 | 7 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Yang Patrick Y | SANA | Stock Option (Right to Buy) | D | 25,00 | 14 000 | 14 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | REICIN ALISE | SANA | Stock Option (Right to Buy) | D | 25,00 | 7 000 | 7 000 | |||||
| 2021-02-03 | 3 | AGARWAL SUNIL | SANA | Common Stock | D | 1 610 000 | ||||||||
| 2021-02-03 | 3 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 147 500 | ||||||||
| 2021-02-03 | 3 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 145 000 | ||||||||
| 2021-02-03 | 3 | GILLIS STEVEN See Footnotes | SANA | Common Stock | I | 145 000 | ||||||||
| 2021-02-03 | 3 | GILLIS STEVEN See Footnotes | SANA | Common Stock | I | 147 500 | ||||||||
| 2021-02-03 | 3 | ARCH Venture Partners X, LLC See Footnotes | SANA | Common Stock | I | 145 000 | ||||||||
| 2021-02-03 | 3 | ARCH Venture Partners X, LLC See Footnotes | SANA | Common Stock | I | 147 500 | ||||||||
| 2021-02-03 | 3 | Hordo Christian | SANA | Common Stock | D | 975 000 | ||||||||
| 2021-02-03 | 3 | Yang Patrick Y | SANA | Common Stock | D | 146 250 | ||||||||
| 2021-02-03 | 3 | MacDonald James J. | SANA | Common Stock | D | 335 000 | ||||||||
| 2021-02-03 | 3 | MacDonald James J. Held by the KOM Trust | SANA | Common Stock | I | 125 000 | ||||||||
| 2021-02-03 | 3 | MacDonald James J. Held by the NMM Trust | SANA | Common Stock | I | 125 000 | ||||||||
| 2021-02-03 | 3 | Mulligan Richard | SANA | Common Stock | D | 2 998 121 | ||||||||
| 2021-02-03 | 3 | Harr Steve Held by Harr Family Irrevocable Trust of 2015 dtd 12/28/2015 | SANA | Common Stock | I | 682 500 | ||||||||
| 2021-02-03 | 3 | Harr Steve | SANA | Common Stock | D | 6 142 500 | ||||||||
| 2021-02-03 | 3 | Bishop Hans Edgar | SANA | Common Stock | D | 3 705 000 | ||||||||
| 2021-02-03 | 3 | Hardy Nathan | SANA | Common Stock | D | 511 250 |
P
Otwarty rynek lub prywatny zakup niepochodnych lub pochodnych papierów wartościowych
S
Otwarty rynek lub prywatna sprzedaż niepochodnych lub pochodnych papierów wartościowych
A
Grant, nagroda lub inne nabycie papierów wartościowych od spółki (np. opcja)
C
Konwersja instrumentu pochodnego
D
Sprzedaż lub przeniesienie papierów wartościowych z powrotem do spółki
F
Zapłata ceny wykonania lub zobowiązania podatkowego z wykorzystaniem części papierów wartościowych otrzymanych od spółki
G
Darowizna papierów wartościowych przez lub na rzecz insidera
K
Swapy kapitałowe i podobne transakcje zabezpieczające
M
Wykonanie lub konwersja pochodnego papieru wartościowego otrzymanego od spółki (takiego jak opcja)
V
Transakcja dobrowolnie zgłoszona na Formularzu 4
J
Inne (wraz z przypisem opisującym transakcję)
